Whole-body MR imaging for staging of malignant tumors in pediatric patients: Results of the american college of radiology imaging network 6660 trial

Radiology

Volumn 266, Issue 2, 2013, Pages 599-609

  Siegel, Marilyn J ^a   Acharyya, Suddhasatta ^b   Hoffer, Frederic A ^c   Brad Wyly, J ^d   Friedmann, Alison M ^e   Snyder, Bradley S ^b   Babyn, Paul S ^f   Khanna, Geetika ^a   Siegel, Barry A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BONE METASTASIS; CANCER STAGING; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INFORMED CONSENT; INTERMETHOD COMPARISON; LUNG METASTASIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SOFT TISSUE SARCOMA; SOLID TUMOR; WHOLE BODY MRI;

AREA UNDER CURVE; BIOPSY; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS; PROSPECTIVE STUDIES; ROC CURVE; UNITED STATES; WHOLE BODY IMAGING;

EID: 84873349452     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112531     Document Type: Article

References (32)

1. Breneman JC, Lyden E, Pappo AS, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2003;21(1):78-84.
2. Pizzo PA, Poplack DG. Neuroblastoma. In: Principles and practice of pediatric oncology. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011;886-922.
3. Nachman JB, Sposto R, Herzog P, et al; Children's Cancer Group. Randomized comparison of low-dose involved-feld radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002;20(18):3765-3771.
4. Pizzo PA, Poplack DG. Ewing sarcoma. In: Principles and practice of pediatric oncology. Philadelphia, Pa: Lippincott Williams & Wilkins, 2011;987-1014.
5. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007;357(22):2277-2284.
6. Ahmed BA, Connolly BL, Shroff P, et al. Cumulative effective doses from radiologic procedures for pediatric oncology patients. Pediatrics 2010;126(4):e851-e858.
7. Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2006. Bethesda, Md: National Cancer Institute, 2008. http://seer.cancer.gov/csr/1975-2006. Accessed August 10, 2009.
8. Lauenstein TC, Freudenberg LS, Goehde SC, et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002;12(8):2091-2099.
9. Eustace S, Tello R, De Carvalho V, Carey J, Melhem E, Yucel EK. Whole body turbo STIR MRI in unknown primary tumor detection. J Magn Reson Imaging 1998;8(3):751-753.
10. Walker R, Kessar P, Blanchard R, et al. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 2000;11(4):343-350.
11. Lauenstein TC, Goehde SC, Herborn CU, et al. Three-dimensional volumetric interpolated breath-hold MR imaging for wholebody tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol 2002;179(2):445-449.
12. Engelhard K, Hollenbach HP, Wohlfart K, Von Imhoff E, Fellner FA. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 2004;14(1):99-105.
13. Hargaden G, O'Connell M, Kavanagh E, Powell T, Ward R, Eustace S. Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging. AJR Am J Roentgenol 2003;180(1):247-252.
14. Iizuka-Mikami M, Nagai K, Yoshida K, et al. Detection of bone marrow and extramedullary involvement in patients with non-Hodgkin's lymphoma by whole-body MRI: comparison with bone and 67Ga scintigraphies. Eur Radiol 2004;14(6):1074-1081.
15. Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology 2004;233(1):139-148.
16. Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 2001;177(1):229-236.
17. Goo HW, Choi SH, Ghim T, Moon HN, Seo JJ. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods. Pediatr Radiol 2005;35(8):766-773.
18. Goo HW, Yang DH, Ra YS, et al. Wholebody MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy. Pediatr Radiol 2006;36(10):1019-1031.
19. Kumar J, Seith A, Kumar A, et al. Wholebody MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT. Pediatr Radiol 2008;38(9):953-962.
20. Laffan EE, O'Connor R, Ryan SP, Donoghue VB. Whole-body magnetic resonance imaging: a useful additional sequence in paediatric imaging. Pediatr Radiol 2004;34(6):472-480.
21. Mazumdar A, Siegel MJ, Narra V, Luchtman-Jones L. Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study. AJR Am J Roentgenol 2002;179(5):1261-1266.
22. Mentzel HJ, Kentouche K, Sauner D, et al. Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 2004;14(12):2297-2302.
23. Metz CE, Wang P-L, Kronman HB. A new approach for testing the significance of differences between ROC curves measured from correlated data. In: Deconinck F, ed. Information processing in medical imaging. The Hague, the Netherlands: Martinus Nijhoff, 1984;432-445.
24. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making 1998;18(1):110-121.
25. Obuchowski NA, Rockette HE. Hypothesis testing of the diagnostic accuracy of multiple diagnostic tests: an ANOVA approach with dependent observations. Commun Stat Simul Comput 1995;24(2):285-308.
26. Obuchowski NA. Multireader, multimodality receiver operating characteristic curve studies: hypothesis testing and sample size estimation using an analysis of variance approach with dependent observations. Acad Radiol 1995;2(Suppl 1):S22-S29; discussion S57-S64, S70-S71 pas.
27. Kellenberger CJ, Miller S F, Khan M, Gilday DL, Weitzman S, Babyn PS. Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol 2004;14(10):1829-1841.
28. Punwani S, Taylor SA, Bainbridge A, et al. Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging. Radiology 2010;255(1):182-190.
29. Frericks BB, Meyer BC, Martus P, Wendt M, Wolf KJ, Wacker F. MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT). J Magn Reson Imaging 2008;27(3):538-545.
30. Brennan DD, Gleeson T, Coate LE, Cronin C, Carney D, Eustace SJ. A comparison of whole-body MRI and CT for the staging of lymphoma. AJR Am J Roentgenol 2005;185(3):711-716.
31. Padhani AR, Koh D-M, Collins DJ. Wholebody diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 2011;261(3):700-718.
32. MacKenzie JD, Vasanawala SS. Advances in pediatric MR imaging. Magn Reson Imaging Clin N Am 2008;16(3):385-402, v.